CS121391A3 - Protein-containing pharmaceutical - Google Patents

Protein-containing pharmaceutical

Info

Publication number
CS121391A3
CS121391A3 CS911213A CS121391A CS121391A3 CS 121391 A3 CS121391 A3 CS 121391A3 CS 911213 A CS911213 A CS 911213A CS 121391 A CS121391 A CS 121391A CS 121391 A3 CS121391 A3 CS 121391A3
Authority
CS
Czechoslovakia
Prior art keywords
protein
containing pharmaceutical
compsn
prepare
new
Prior art date
Application number
CS911213A
Other languages
English (en)
Inventor
Johann Eibl
Ludwig Pichler
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of CS121391A3 publication Critical patent/CS121391A3/cs
Publication of CZ280004B6 publication Critical patent/CZ280004B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CS911213A 1990-08-16 1991-04-26 Farmaceutický preparát s obsahem proteinu CZ280004B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (de) 1990-08-16 1990-08-16 Protein c-hältige pharmazeutische präparation
EP91890012A EP0471660B1 (de) 1990-08-16 1991-01-28 Protein C zur Schmerzbekämpfung

Publications (2)

Publication Number Publication Date
CS121391A3 true CS121391A3 (en) 1992-02-19
CZ280004B6 CZ280004B6 (cs) 1995-09-13

Family

ID=3519039

Country Status (12)

Country Link
EP (3) EP0533209B1 (cs)
JP (1) JP2530770B2 (cs)
AT (6) AT402260B (cs)
CA (1) CA2041380C (cs)
CZ (1) CZ280004B6 (cs)
DE (3) DE59108638D1 (cs)
DK (3) DK0533210T3 (cs)
ES (3) ES2102435T3 (cs)
HR (1) HRP921237A2 (cs)
HU (1) HUT60147A (cs)
RU (1) RU2066550C1 (cs)
YU (1) YU77591A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE19608218A1 (de) * 1995-03-21 1996-09-26 Immuno Ag Mittel zur subkutanen Verabreichung von Protein C
EP0733371B1 (de) * 1995-03-21 2002-06-19 Baxter Aktiengesellschaft Mittel zur subkutanen Verabreichung von Protein C
US20080293631A1 (en) * 2005-01-07 2008-11-27 Christopher John Jackson Treatment for Autoimmune and Inflammatory Conditions
JP6273272B2 (ja) * 2012-07-04 2018-01-31 ジージー バイオテック エルエルシー 炎症性皮膚障害の治療
ES2890623T3 (es) 2014-04-16 2022-01-20 Zz Biotech Llc Uso del análogo de APC para curar heridas
DK3137102T3 (da) 2014-04-16 2021-10-11 Zz Biotech Llc Apc til anvendelse til behandling af unormal kutan ardannelse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
CA2041380A1 (en) 1992-02-17
EP0533210A1 (de) 1993-03-24
HU911348D0 (en) 1991-10-28
EP0471660B1 (de) 1995-08-23
CA2041380C (en) 1997-10-07
DE59108697D1 (de) 1997-06-05
ES2103861T3 (es) 1997-10-01
JPH04230633A (ja) 1992-08-19
ATA20492A (de) 1997-10-15
EP0533209A1 (de) 1993-03-24
EP0471660A2 (de) 1992-02-19
DE59108638D1 (de) 1997-04-30
EP0533210B1 (de) 1997-05-02
RU2066550C1 (ru) 1996-09-20
HUT60147A (en) 1992-08-28
AT403763B (de) 1998-05-25
DK0533210T3 (da) 1997-11-03
HRP921237A2 (en) 1995-10-31
ATE150649T1 (de) 1997-04-15
ES2102435T3 (es) 1997-08-01
AT402260B (de) 1997-03-25
DK0533209T3 (da) 1997-09-22
ES2080289T3 (es) 1996-02-01
EP0471660A3 (en) 1992-04-15
CZ280004B6 (cs) 1995-09-13
YU77591A (sh) 1995-10-24
DE59106292D1 (de) 1995-09-28
ATE152354T1 (de) 1997-05-15
EP0533209B1 (de) 1997-03-26
ATA20392A (de) 1997-07-15
ATA169790A (de) 1996-08-15
JP2530770B2 (ja) 1996-09-04
ATE126699T1 (de) 1995-09-15
DK0471660T3 (da) 1995-12-18
AT403439B (de) 1998-02-25

Similar Documents

Publication Publication Date Title
LV10357A (lv) Jauna farmaceitiska kompozicija tas iegusanas panemiens un tas pielietojums kunga un zarnu trakta slimibu arstesanai
EP0442878A4 (en) Derivatives of tryptophan as cck antagonists
DE3687099D1 (de) Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen.
EP0295721A3 (en) Promotion of healing of meniscal tissue
HRP921237A2 (en) Protein c containing pharmaceutical preparation
FI843005A7 (fi) 1,6-naftyridioni-johdannaiset, niiden valmistusmenetelmä ja käyttö suonisairauksien estossa
EP0321866A3 (en) High-pressure discharge lamp
HU891455D0 (en) Use of optically clean r-niguldipin and its derivatives for treating diseases
ZA883744B (en) Promotion of healing of meniscal tissue
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
HUT51030A (en) High-pressure sodium discharge lamp
HUT52638A (en) High-pressure discharge lamp
HUT51413A (en) High-pressure discharge lamp
IT1177973B (it) Materiali ricombinanti e metodi per la produzione di peptide-iii attiva tore di tessuto connetivo umano e relativi analoghi
EP0279249A3 (en) High-pressure discharge lamp
HUT45793A (en) Low-pressure mercury-arc discharge lamp
FR2540500B1 (fr) Produits derives de la mitomycine et son application au traitement des maladies neoplasiques
HUT49964A (en) Wall-stabilized high-pressure discharge source of light
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
EP0417298A4 (en) Detection of human tissue factor activator
ES2011230A4 (es) Derivados peptidos del 3 - aminodihidrotiofeno - 2 - uno, procesos para la preparacion y uso terapeutico
CS942287A1 (en) Tester of high-pressure sodium vapour lamps' thyristor starters
KR900009212A (ko) 공작물의 자동공급 및 배출장치
DD262196B1 (de) Saugduese zum abschwenken von vorsatzbogen
SE8700939D0 (sv) Forfarande for framstellning av presskroppar och anordning for genomforande av forfarandet

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20040426